September 30, 2025

Enovis Corporation (ENOV) Stock Analysis: Unlocking a 64.57% Potential Upside in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, has caught the eye of many investors with its robust potential for growth. With a..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking a 257.59% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is making waves in the biotechnology sector, driven by an impressive 257.59% potential upside according to analyst ratings. As a clinical-stage..

Twist Bioscience Corporation (TWST): Investor Outlook Reveals 56% Upside Potential

Twist Bioscience Corporation (NASDAQ: TWST), a leader in the synthetic DNA sector, has been capturing attention with its innovative contributions to healthcare and diagnostics. Based in..

Clover Health Investments (CLOV): Analyst Ratings Suggest 16.99% Upside Potential for This Healthcare Innovator

Clover Health Investments, Corp (CLOV) is at the forefront of transforming healthcare delivery in the United States. With a market capitalization of $1.64 billion, this Delaware-based..

Surgery Partners, Inc. (SGRY) Stock Analysis: 40% Potential Upside Draws Investor Attention

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, operates an extensive network of surgical facilities and ancillary services across the United States...

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Potential 24.61% Upside as Biotech Innovator Advances

Scholar Rock Holding Corporation (NASDAQ: SRRK), a promising player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach to treating..

CG Oncology, Inc. (CGON) Growth Potential: A Biotech Innovator with 63% Upside

CG Oncology, Inc. (NASDAQ: CGON) is capturing the interest of savvy investors with a promising outlook in the dynamic biotechnology sector. Specializing in bladder cancer therapeutics,..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Gem With 75% Upside Potential

Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the biotechnology sector, is making waves with its promising outlook and robust financial performance. Based in Coral Gables,..

Protagonist Therapeutics, Inc. (PTGX) Investor Outlook: Potential Growth Amid Biotech Innovations

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a dynamic player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of innovative peptide therapeutics...

Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 24% Upside in Healthcare Innovation

Investors with a keen eye on the healthcare sector may find Privia Health Group, Inc. (NASDAQ: PRVA) an intriguing prospect. As a national physician-enablement company, Privia..

Ardent Health, Inc. (ARDT) Stock Report: Robust 43.81% Upside Potential for Healthcare Investors

Ardent Health, Inc. (NYSE: ARDT) stands as a formidable player in the U.S. healthcare sector, operating a broad network of hospitals and clinics that cater to..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 43.96% Upside Potential in the Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM) is emerging as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. As the..

Arcellx, Inc. (ACLX) Stock Analysis: A Promising Upside of Nearly 43% as Analysts Rally Behind Its Biotech Innovations

Arcellx, Inc. (NASDAQ: ACLX), a dynamic player in the biotechnology sector, is capturing attention with its pioneering immunotherapies aimed at tackling cancer and other severe diseases...

Metsera, Inc. (MTSR) Stock Analysis: Exploring a 17% Upside Potential in the Biotech Sector

Metsera, Inc. (NASDAQ: MTSR) is quickly gaining attention in the biotechnology sector, thanks to its innovative approach to tackling obesity and related metabolic disorders. With a..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Unveiling a 26.65% Potential Upside for Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, specifically within the drug manufacturers specializing in specialty and generic medications, is garnering attention from..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 55% Potential Upside Amid Growing Demand for Mental Health Services

LifeStance Health Group, Inc. (NASDAQ: LFST) is carving a significant niche within the healthcare sector, specifically in the medical care facilities industry. The company, headquartered in..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 127.81% Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands at the intriguing intersection of innovation and potential within the healthcare sector. Specializing in the development of oral small-molecule and..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a Promising 27% Upside Potential

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of biotechnology innovation, leveraging cutting-edge CRISPR/Cas9 gene-editing technology to develop groundbreaking treatments for a wide array of..

Apellis Pharmaceuticals (APLS) Stock Analysis: Biotechnology Innovator with 65% Upside Potential

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent player in the biotechnology sector, is attracting attention with its promising pipeline and significant potential upside. With a market..

Zai Lab Limited (ZLAB) Stock Analysis: Unpacking an Impressive 68% Potential Upside

Zai Lab Limited (NASDAQ: ZLAB) presents a compelling investment opportunity in the biotechnology sector, with analysts forecasting a considerable 68.26% potential upside from its current stock..

Search

Funds

September 30, 2025

Search

Funds

September 30, 2025

FTSE 100

Funds